Table 1 Demographic Data and Results
From: Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals
No. | gender | Age (y) | Wt (Kg) | Ht (cm) | CDC | CD4% (cell/mm3) | Regimen* | Chosen flavors | NNRTI Trough level **(mg/L) | Reason of discontinue FLAVORx | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Â | Â | Â | Â | VisitI | VisitII | VisitI | VisitII | Â |
1 | F | 6.7 | 16 | 112.5 | B | 13%(277) | AZT 1cap+7 mlX2 3TC 1/2 tabX2 NVP 3/4 tabX2 | S | x | 3.94 | 4.19 | Spicy taste |
2 | M | 5.5 | 17 | 111 | B | 39%(1108) | AZT 1 cap +6 mlX2 3TC 7 mlX2 NVP 3/4 tabX2 | S, O | x | 14.80 | 7.01 | Child prefer to mix ARV with water |
3 | F | 3.5 | 12.5 | 92.5 | A | 7%(342) | 3TC 5 mlX2 EFV 200 mg d4T 1/3 tabx2 | O | x | 11.88 | 8.29 | Spicy taste |
4 | F | 4.2 | 14 | 97 | A | 10%(210) | AZT 1 cap +5 mlx2 3TC 6 mlx2 EFV 200 mg | S | S | 2.14 | 1.55 | Â |
5 | M | 4.8 | 17.2 | 106 | A | 24%(1122) | AZT 1 cap +7 mlX2 3TC 1 tab X2 NVP 3/4 tabX2 | S, O | S,G | 5.66 | 5.60 | Â |
6 | M | 5.3 | 12.5 | 93 | B | 6%(459) | AZT 1 cap +4 mlX2 3TC 5 mlx2 NVP 1/2 tabx2 | S | S | 3.05 | 3.45 | Â |
7 | F | 4.5 | 14 | 99 | C | 17%(356) | AZT 1 cap +5 mlX2 ddI(170 mg) 1 × 1 | S,O,G | G | - | - |  |
8 | M | 4 | 15 | 96 | A | 42%(2278) | AZT 1 cap +5 ml 3TC 6 mlx2 EFV 200 mg | S | x | 1.93 | 2.45 | Vomiting |
9 | F | 7.5 | 29.6 | 126 | A | 29%(614) | AZT 2 cap X2 3TC 1 tab X2 EFV 350 mg | S | x | - | - | Child prefer to mix ARV with water |
10 | M | 4.1 | 15 | 99 | C | 22%(945) | AZT 1 cap +5 mlX2 3TC 7 mlX2 EFV 250 mg | S,O | S | 3.18 | 0.00 Repeat *** | Â |
11 | F | 4.6 | 23 | 106 | A | 25%(1224) | 3TC 1 tab x2 EFV 300 mg ddI(115) 2 × 1 | S | S | 1.40 | 3.78 |  |
12 | M | 1 | 11.5 | 84.5 | C | 38%(1732) | 3TC 4 mlx2 NVP 1/2 tab X2 d4T 10 mgx2 | O | S,G,B | 3.51 | 4.30 | Â |
13 | F | 4.8 | 14.1 | 97 | A | 35%(1428) | AZT 1 cap +5 mlX2 3TC 1 tabX2 EFV 250 mg | S | S,B | Â | Â | Â |
14 | F | 2 | 10.2 | 83 | B | 24%(761) | AZT 1 cap +2 ml × 2 3TC 5 ml × 2 Kaletra 1.4 ml × 2 | O | S |  |  |  |
15 | F | 4.7 | 11.6 | 93 | B | 15%(250) | 3TC 6 mlX2 NVP 1/2 tabX2 d4T 15 mgx2 | S | S | Â | Â | Â |
16 | M | 4 | 13.9 | 95.5 | C | 24%(960) | AZT 1 cap +4 mlx2 3TC 6 mlx2 EFV 200 mg | S | S | Â | Â | Â |
17 | F | 5.5 | 14 | 104 | B | 22%(591) | AZT 1 cap +4 mlX2 3TC 1/2 tab x2 NVP 3/4 tabx2 | S | S | Â | Â | Â |
18 | M | 4.3 | 15.1 | 103 | C | 26%(1261) | AZT 1 cap +5 mlX2 3TC 7 mlX2 EFV 200 mg | S | S | Â | Â | Â |
19 | M | 7.7 | 17.5 | 105 | B | 23%(915) | 3TC 1/2 tabX2 EFV 250 mg d4T 15 mgX2 | O,G | G | Â | Â | Â |
20 | F | 5.4 | 20 | 105.5 | B | 41%(1137) | AZT 1 cap +5 mlX2 3TC 1tabX2 EFV 250 mg | S,O | B,A | Â | Â | Â |
21 | F | 9.8 | 18 | 119 | B | 27%(1086) | AZT 1 cap +8 mlX2 3TC 1 tabX2 EFV 300 mg | O,G | G | Â | Â | Â |
22 | F | 8.8 | 18 | 116.5 | B | 6%(112) | AZT 1 cap +8 mlX2 3TC 1/2 tabX2 NVP 3/4 tabX2 | S | G | Â | Â | Â |
23 | F | 1.8 | 10 | 82 | A | 33%(1933) | AZT 1 cap +1 mlx2 3TC 5 mlX2 Kaletra 1.4 ml × 2 | S,O | O |  |  |  |
24 | M | 8 | 22.6 | 119 | B | 25%(809) | 3TC 1 tabX2 d4T 1/2 tabx2 NVP 3/4 tab x2 | S,O | x | Â | Â | Child prefer to mix ARV with water |
25 | F | 4 | 15.2 | 94 | B | 28%(817) | 3TC 1/2 tabX2 EFV 200 mg d4T 15 mg | S,B | S,B | Â | Â | Â |
26 | F | 6.3 | 16.9 | 109 | C | 26%(723) | AZT 1 cap +5 mlX2 3TC 1/2 tabX2 NVP 3/4 tabX2 | O | O | Â | Â | Â |
27 | F | 6.7 | 18.3 | 110 | C | 40%(1109) | 3TC 7 mlX2 EFV 250 mg d4T 15 mg | S,O | B | Â | Â | Â |
28 | M | 4.5 | 15 | 102.5 | A | 28%(1076) | 3TC 1/2 tabX2 EFV 200 mg d4T 15 mgX2 | G | G | Â | Â | Â |
29 | F | 6 | 19.2 | 110 | A | 12%(551) | AZT 1 cap +8 mlX2 3TC 1/2 tab X2 NVP 3/4 tabX2 | S,O | G | Â | Â | Â |
30 | M | 5.7 | 20 | 114 | C | 17%(345) | AZT 1 cap +8 mlX2 3TC 1 tabX2 EFV 300 mg | S | S | Â | Â | Â |